Neuronetics (STIM) Operating Expenses (2017 - 2026)

Neuronetics (STIM) has 10 years of Operating Expenses data on file, last reported at $25.1 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $25.1 million, down 5.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.1 million (up 6.92% YoY), and the FY2025 annual result was $103.7 million, up 16.93% from the prior year.
• Operating Expenses declined to $25.1 million in Q1 2026 per STIM's latest filing, from $26.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $26.8 million in Q1 2025 and troughed at $19.9 million in Q1 2024.
• A 5-year average of $22.6 million and a median of $21.5 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses fell 8.89% in 2023, then soared 34.12% in 2025.
• A 5-year view of Operating Expenses shows it stood at $21.5 million in 2022, then dropped by 6.21% to $20.2 million in 2023, then jumped by 30.53% to $26.4 million in 2024, then gained by 1.45% to $26.7 million in 2025, then fell by 5.97% to $25.1 million in 2026.
• Business Quant data shows STIM's Operating Expenses at $25.1 million in Q1 2026, $26.7 million in Q4 2025, and $24.4 million in Q3 2025.